Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Злокачественные новообразования костей и суставных хрящей: остеосаркома, саркома Юинга

Список литературы

  1. Fletcher C.D.M. et al. WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. 2013. 468 p.
  2. Doyle L.A. Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone // Cancer. John Wiley and Sons Inc., 2014. Vol. 120, № 12. P. 1763-1774.
  3. Ritter J., Bielack S.S. Osteosarcoma // Ann. Oncol. 2010. Vol. 21. P. 320-325.
  4. Ottaviani G., Jaffe N. The epidemiology of osteosarcoma // Cancer Treatment and Research. Kluwer Academic Publishers, 2009. Vol. 152. P. 3-13.
  5. Sybil Biermann J. et al. Bone Cancer. NCCN Guidelines Version 1.2020. 2019.
  6. Van Den Berg H. et al. Ewing tumors in infants // Pediatr. Blood Cancer. 2008. Vol. 50, № 4. P. 761-764.
  7. Shi Z. et al. Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell lymphoma // Leukemia and Lymphoma. 2013. Vol. 54, № 10. P. 2122-2130.
  8. Sobin L.H., Gospodarowicz M.K., Wittekind C. TNM Classification of Malignant Tumours. Wiley, 2011. 201 p.
  9. Potratz J. et al. Ewing sarcoma: Clinical state-of-the-art // Pediatric Hematology and Oncology. 2012. Vol. 29, № 1. P. 1-11.
  10. Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. М.: Издательская группа РОНЦ. Практическая медицина, 2012. 684 p.
  11. Malawer M.M., Sugarbaker P.H. Musculoskeletal Cancer Surgery - Treatment of Sarcomas and Allied Diseases. Springer, 2001. 626 p.
  12. Bekiesinska-Figatowska M. et al. CNS Metastases from Bone and Soft Tissue Sarcomas in Children, Adolescents, and Young Adults: Are They Really So Rare? 2017.
  13. Bundscherer F., Deeg K.H., Seiler A. [Sonographic diagnosis of solid space-occupying abdominal lesions in childhood]. // Monatsschr. Kinderheilkd. 1987. Vol. 135, № 1. P. 30-35.
  14. Youssef G., Links M. The prevention and management of cardiovascular complications of chemotherapy in patients with cancer // American Journal of Cardiovascular Drugs. 2005. Vol. 5, № 4. P. 233-243.
  15. Traina F. et al. Current concepts in the biopsy of musculoskeletal tumors: AAOS exhibit selection // J. Bone Jt. Surg. - Am. Vol. Journal of Bone and Joint Surgery Inc., 2015. Vol. 97, № 2. P. e7(1).
  16. Kubo T. et al. A meta-analysis supports core needle biopsy by radiologists for better histological diagnosis in soft tissue and bone sarcomas // Medicine (United States). Lippincott Williams and Wilkins, 2018. Vol. 97, № 29. P. e11567.
  17. Мацко Д.Е. Саркомы костей: классификация, гистологическое строение, особенности морфологической диагностики // Практическая онкология. 2010. Vol. 11, № 1. P. 1-10.
  18. Pohlig F. et al. Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. // Eur. J. Med. Res. 2012. Vol. 17. P. 29.
  19. Mankin H.J., Mankin C.J., Simon M.A. The hazards of the biopsy, revisited: For the members of the musculoskeletal tumor society // J. Bone Jt. Surg. - Ser. A. 1996. Vol. 78, № 5. P. 656-663.
  20. Clark C.R. et al. The effect of biopsy-hole shape and size on bone strength. // J. Bone Joint Surg. Am. 1977. Vol. 59, № 2. P. 213-217.
  21. Егоренков В.В., Бит-Сава Е.М., Молчанов М.С. Правила забора материала для морфологического исследования // Практическая онкология. 2017. Vol. 18, № 4. P. 336-342.
  22. Ladenstein R. et al. Primary disseminated multifocal Ewing sarcoma: Results of the EuroEWING 99 trial // J. Clin. Oncol. 2010. Vol. 28, № 20. P. 3284-3291.
  23. Biswas B. et al. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol // Journal of Surgical Oncology. John Wiley and Sons Inc., 2015. Vol. 111, № 6. P. 683-689.
  24. Whelan J.S. et al. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment f on behalf of the EURAMOS collaborators // Ann. Oncol. 2015. Vol. 26. P. 407-414.
  25. Smeland S. et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort // Eur. J. Cancer. Elsevier Ltd, 2019. Vol. 109. P. 36-50.
  26. Laitinen M. et al. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma // Bone Jt. J. British Editorial Society of Bone and Joint Surgery, 2015. Vol. 97B, № 12. P. 1698-1703.
  27. Cesari M. et al. Periosteal osteosarcoma // Cancer. 2011. Vol. 117, № 8. P. 1731-1735.
  28. Womer R.B. et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized ewing sarcoma: A report from the children’s oncology group // J. Clin. Oncol. American Society of Clinical Oncology, 2012. Vol. 30, № 33. P. 4148-4154.
  29. Miser J.S. et al. Treatment of metastatic Ewing’s sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children’s Cancer Group and Pediatric Oncology Group study // J. Clin. Oncol. 2004. Vol. 22, № 14. P. 2873-2876.
  30. Tenneti P. et al. Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing’s Sarcoma: A Systematic Review // Sarcoma. Hindawi Limited, 2018. Vol. 2018.
  31. Heck R.K. General principles of tumors // Campbells Operative Orthopaedics. 10th edition. 2004. P. 733-792.
  32. Rougraff B.T. et al. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur: A long-term oncological functional, and quality-of-life study // J. Bone Jt. Surg. -Ser. A. Journal of Bone and Joint Surgery Inc., 1994. Vol. 76, № 5. P. 649-656.
  33. Gitelis S. et al. Principles of limb salvage surgery // Chapman's Orthopaedic Surgery, 3rd edition. 2001. P. 3309-3381.
  34. Marulanda G.A. et al. Use of extendable prostheses: A limb-salvaging alternative for patients with malignant bone tumors // Expert Review of Medical Devices. 2008. Vol. 5, № 4. P. 467-474.
  35. 35. Joffe L. et al. Nutritional status and clinical outcomes in pediatric patients with solid tumors: A systematic review of the literature // Seminars in Oncology. W.B. Saunders, 2019. Vol. 46, № 1. P. 48-56.
  36. Isenring E., Elia M. Which screening method is appropriate for older cancer patients at risk for malnutrition? // Nutrition. Elsevier Inc., 2015. Vol. 31, № 4. P. 594-597.
  37. Martin L. et al. Diagnostic criteria for the classification of cancer-associated weight loss // J. Clin. Oncol. American Society of Clinical Oncology, 2015. Vol. 33, № 1. P. 90-99.
  38. Manary M.J., Sandige H.L. Management of acute moderate and severe childhood malnutrition // BMJ. BMJ, 2008. Vol. 337, № 7680. P. 1227-1230.
  39. van den Broeck J., Eeckels R., Massa G. Validity of Single-Weight Measurements to Predict Current Malnutrition and Mortality in Children // J. Nutr. 1996. Vol. 126, № 1. P. 113-120.
  40. Meijers J.M.M. et al. Nutritional care; do process and structure indicators influence malnutrition prevalence over time? // Clin. Nutr. Churchill Livingstone, 2014. Vol. 33, № 3. P. 459-
  41. Muscaritoli M. et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “ cachexia-anorexia in chronic wasting diseases” and “ nutrition in geriatrics” // Clin. Nutr. Clin Nutr, 2010. Vol. 29, № 2. P. 154-159.
  42. Kondrup J. et al. ESPEN guidelines for nutrition screening 2002 // Clin. Nutr. Churchill Livingstone, 2003. Vol. 22, № 4. P. 415-421.
  43. Rickard K.A. et al. Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease // Ann. Surg. Lippincott, Williams, and Wilkins, 1979. Vol. 190, № 6. P. 771-781.
  44. Joosten K.F.M., Kerklaan D., Verbruggen S.C.A.T. Nutritional support and the role of the stress response in critically ill children // Current Opinion in Clinical Nutrition and Metabolic Care. Lippincott Williams and Wilkins, 2016. Vol. 19, № 3. P. 226-233.
  45. Arends J. et al. ESPEN guidelines on nutrition in cancer patients // Clin. Nutr. Churchill Livingstone, 2017. Vol. 36, № 1. P. 11-48.
  46. Koletzko B. et al. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatri // Journal of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr, 2005. Vol. 41, № SUPPL. 2. 87 p.
  47. August D.A., Huhmann M.B. A.S.P.E.N. Clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation // Journal of Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr, 2009. Vol. 33, № 5. P. 472-500.
  48. Абузарова Г.Р. et al. Обезболивание взрослых и детей при оказании медицинской помощи. Методические рекомендации. ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России., 2016. 94 p.
  49. Punzalan M., Hyden G. The role of physical therapy and occupational therapy in the rehabilitation of pediatric and adolescent patients with osteosarcoma // Cancer Treatment and Research. 2009. Vol. 152. P. 367-384.
  50. Феденко А.А. et al. Практические рекомендации по лечению первичных злокачественных опухолей костей (остеосаркомы, саркомы Юинга) // Злокачественные опухоли : Практические рекомендации RUSSCO. 2019. Vol. 9. P. 259-271.
  51. Mavrogenis A.F. et al. How should musculoskeletal biopsies be performed? // Orthopedics. Slack Incorporated, 2014. Vol. 37, № 9. P. 585-588.
  52. Ruggieri P. et al. Outcome of expandable prostheses in children // J. Pediatr. Orthop. 2013. Vol. 33, № 3. P. 244-253.
  53. Andreou D. et al. The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. // Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2011. Vol. 22, № 5. P. 1228-1235.
  54. Kandel R. et al. Surgical margins and handling of soft-tissue sarcoma in extremities: A clinical practice guideline // Curr. Oncol. Multimed Inc., 2013. Vol. 20, № 3. P. e247.
  55. Casali P.G., Blay J.-Y. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann. Oncol. 2010. Vol. 21. P. 198-203.
  56. Kotz R.I. Progress in musculoskeletal oncology from 1922 - 2012 // Int. Orthop. Springer Verlag, 2014. Vol. 38, № 5. P. 1113-1122.
  57. Hosalkar H.S., Dormans J.P. Limb Sparing Surgery for Pediatric Musculoskeletal Tumors // Pediatric Blood and Cancer. 2004. Vol. 42, № 4. P. 295-310.
  58. Groundland J.S., Binitie O. Reconstruction After Tumor Resection in the Growing Child // Orthopedic Clinics of North America. W.B. Saunders, 2016. Vol. 47, № 1. P. 265-281.
  59. Gur E. et al. The Use of Free Vascularized Fibular Grafts for Reconstruction of Segmental Bone Defects // Musculoskeletal surgery, part 4, Oncology. 2009. P. Chapter 28.
  60. Capanna R. et al. A New Reconstructive Technique for Intercalary Defects of Long Bones: The Association of Massive Allograft with Vascularized Fibular Autograft. Long-Term Results and Comparison with Alternative Techniques // Orthopedic Clinics of North America. 2007. Vol. 38, № 1. P. 51-60.
  61. Zaretski A. et al. Biological reconstruction of bone defects: The role of the free fibula flap // Journal of Children’s Orthopaedics. British Editorial Society of Bone and Joint Surgery, 2011. Vol. 5, № 4. P. 241-249.
  62. Manfrini M. et al. Imaging of Vascularized Fibula Autograft Placed Inside a Massive Allograft in Reconstruction of Lower Limb Bone Tumors // Am. J. Roentgenol. American Roentgen Ray Society, 2004. Vol. 182, № 4. P. 963-970.
  63. Hilven P.H. et al. The vascularised fibular graft for limb salvage after bone tumour surgery: A multicentre study // Bone Jt. J. British Editorial Society of Bone and Joint Surgery, 2015. Vol. 97-B, № 6. P. 853-861.
  64. Goorin A.M. et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: Analysis of 32 patients // J. Clin. Oncol. 1984. Vol. 2, № 5. P. 425-431.
  65. Tabone M.D. et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy // J. Clin. Oncol. American Society of Clinical Oncology, 1994. Vol. 12, № 12. P. 2614-2620.
  66. Ferrari S. et al. Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival // Journal of Clinical Oncology. American Society of Clinical Oncology, 2003. Vol. 21, № 4. P. 710-715.
  67. Bielack S. et al. Osteosarcoma: The COSS experience // Cancer Treatment and Research. 2009. Vol. 152. P. 289-308.
  68. Abbo O. et al. Bilateral anterior sternothoracotomy (clamshell incision): A suitable alternative for bilateral lung sarcoma metastasis in children // World J. Surg. Oncol. BioMed Central Ltd., 2014. Vol. 12, № 1. P. 233.
  69. Kager L. et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols // J. Clin. Oncol. 2003. Vol. 21, № 10. P. 2011-2018.
  70. Harting M.T., Blakely M.L. Management of osteosarcoma pulmonary metastases // Semin. Pediatr. Surg. W.B. Saunders, 2006. Vol. 15, № 1. P. 25-29.
  71. Castagnetti M., Delarue A., Gentet J.C. Optimizing the surgical management of lung nodules in children with osteosarcoma: Thoracoscopy for biopsies, thoracotomy for resections // Surg. Endosc. Other Interv. Tech. 2004. Vol. 18, № 11. P. 1668-1671.
  72. Kayton M.L. Pulmonary Metastasectomy in Pediatric Patients // Thoracic Surgery Clinics. 2006. Vol. 16, № 2. P. 167-183.
  73. Fernandez-Pineda I. et al. Patients with osteosarcoma with a single pulmonary nodule on computed tomography: A single-institution experience // Journal of Pediatric Surgery. 2012. Vol. 47, № 6. P. 1250-1254.
  74. Goncalves de Oliveira-Filho A., Sbragia Neto L., Epelman S. Median sternotomy for the resection of bilateral pulmonary metastases in children // Pediatr. Surg. Int. 1998. Vol. 13. P. 560563.
  75. Fuchs J. et al. Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors // Surgical Oncology. 2008. Vol. 17, № 4. P. 323-
  76. Tsai J., Mattei P. Median sternotomy for bilateral pulmonary metastasectomy in children // J. Pediatr. Surg. W.B. Saunders, 2012. Vol. 47, № 7. P. 1345-1348.
  77. Heaton T.E., Davidoff A.M. Surgical treatment of pulmonary metastases in pediatric solid tumors // Semin. Pediatr. Surg. W.B. Saunders, 2016. Vol. 25, № 5. P. 311-317.
  78. Jordan K. et al. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009 // Supportive Care in Cancer. 2011. Vol. 19, № SUPPL. 1. P. S37-42.
  79. High-Dose Methotrexate, Leucovorin and Glucarpidase Dosing, Administration, and Monitoring-Adult/Pediatric-Inpatient Clinical Practice Guideline.
  80. Howard S.C. et al. Preventing and Managing Toxicities of High-Dose Methotrexate // Oncologist. Alphamed Press, 2016. Vol. 21, № 12. P. 1471-1482.
  81. Grier H.E. et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone // N. Engl. J. Med. N Engl J Med, 2003. Vol. 348, № 8. P. 694-701.
  82. Dirksen U. Ewing 2008. 2018. P. 163.
  83. Seddon B.M. et al. Fatal radiation myelopathy after high-dose Busulfan and Melphalan chemotherapy and radiotherapy for Ewing’s sarcoma: A review of the literature and implications for practice // Clin. Oncol. 2005. Vol. 17, № 5. P. 385-390.
  84. Lin P.P. et al. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma // Cancer. 2007. Vol. 109, № 3. P. 603-611.
  85. Ahmed S.K. et al. Pelvis Ewing sarcoma: Local control and survival in the modern era // Pediatr. Blood Cancer. John Wiley and Sons Inc., 2017. Vol. 64, № 9.
  86. Pan H.Y. et al. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and R0 resection // Int. J. Radiat. Oncol. Biol. Phys. Elsevier Inc., 2015. Vol. 92, № 2. P. 349-357.
  87. Dirksen U. et al. High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008 // Journal of Clinical Oncology. American Society of Clinical Oncology, 2019. Vol. 37, № 34. P. 3192-3202.
  88. Paulino A.C., Mai W.Y., Teh B.S. Radiotherapy in metastatic ewing sarcoma // Am. J. Clin. Oncol. Cancer Clin. Trials. 2013. Vol. 36, № 3. P. 283-286.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*